Riskpilot← Back to searchSign inGet full accessLipid Systems Sweden AB
ABActiveOrg 5568056831Spännarhyttan 33 BManufacture of oils and fats · NACE 1041Est. 20102 employees
Revenue 2025
SEK 3,2M
0% vs 2024
EBITDA margin
15.6%
+40% vs 2024
Equity ratio
76.8%
Financial strength
Net profit 2025
SEK 389K
+87% vs 2024
| Revenue | SEK 3,2M | +0% |
| EBITDA | SEK 497K | +40% |
| Net profit | SEK 389K | +87% |
| Total assets | SEK 6,1M | -1% |
| Equity | SEK 4,7M | +0% |
| Employees | 2 | — |
Legal name
Lipid Systems Sweden AB
Org number
5568056831
Legal form
Aktiebolag
NACE code
1041 · Manufacture of oils and fats
Founded
20 april 2010
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Lipid Systems AB kommer att bedriva lipidkemisk verksamhet. Extraktion och rening av lipider i laboratorieskala, pilotskala och produktionsskala. Formulering av lipidbaserade bärarsystem för läkemedel-, hälsokost- samt livsmedelsapplikationer.
Address
Spännarhyttan 33 B
Phone
+46240653037
Email
jorgen@lipidsystems.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 7 609 | 6 664 | 4 683 | 3 194 | 3 178 |
| Staff expenses | — | — | — | — | −1 561 |
| EBITDA | 3 680 | 2 711 | 760 | 354 | 497 |
| Depreciation & amort. | −85 | −207 | −230 | −240 | −232 |
| EBIT | 3 595 | 2 504 | 530 | 114 | 266 |
| Net financials | 49 | −1 | 60 | 83 | 39 |
| Profit before tax | 2 651 | 2 452 | 1 065 | 267 | 496 |
| Tax | −558 | −507 | −201 | −59 | −107 |
| Net profit | 2 093 | 1 945 | 864 | 208 | 389 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 5 557 | 6 417 | 6 165 | 6 174 | 6 121 |
| Equity | 2 195 | 3 640 | 4 505 | 4 713 | 4 702 |
| Long-term debt | 559 | 303 | 20 | 0 | — |
| Short-term debt | 1 314 | 934 | 577 | 468 | 618 |
| Total debt | 1 873 | 1 237 | 597 | 468 | 618 |
EBITDA margin
15.6%
This company
15.8%
Market median
+1% vs market
20212025
Equity ratio
76.8%
This company
38.2%
Market median
+101% vs market
20212025
Return on equity
8.3%
This company
18.4%
Market median
-55% vs market
20212025
Net profit margin
12.2%
This company
8.1%
Market median
+51% vs market
20212025
Asset turnover
0.52×
This company
1.12×
Market median
-54% vs market
20212025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PE Chief Executive Officer | Chief Executive Officer | 2020 |
JR Audit | Audit | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (1) | ||
| Chairman | 2020 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Lipid Systems Sweden AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Per Erik Jörgen Våger | Chief Executive Officer | 0 companies |
| Jan Rolf Hultelid | Audit | 0 companies |
| Jan Peter Svensson | Chairman | 0 companies |
| Hanna Karin Sand | Deputy Board Member | 0 companies |